INTRODUCTION
The evolutionarily conserved Ccr4-Not complex is important for multiple cellular functions. It is involved in several aspects of the mRNA regulatory pathways (for reviews, see [1, 2] ). Besides that, the E3 ligase activity of yeast Not4p and human CNOT4 subunits [3, 4] implicates the Ccr4-Not complex in the protein ubiquitination/degradation pathways [3, 5] . Moreover, members of the Ccr4-Not complex are associated with various functions in several species, both in the nucleus and in the cytoplasm. These include involvement in DNA repair and histone methylation in yeast [6, 7] , spindle positioning and regulation of microtubule length in Caenorhabditis elegans [8] and spermatogenesis in mice [9] .
The Ccr4-Not complex may influence the synthesis of mRNA molecules in several ways. It has been reported that some yeast Ccr4-Not subunits interact both physically and genetically with TBP (TATA-binding protein), TAFs (TBP-associated factors), and other regulators of TBP binding, indicating direct regulation of gene expression at the core promoter through binding of these basal transcription factors (reviewed in [10] ). The Ccr4-Not complex may also influence gene transcription by affecting chromatin structure [7, 11, 12] or by repressing the nuclear receptor-mediated transcription in a ligand-dependent manner via CNOT1 [13] . Two other human CNOT proteins, CNOT2 and CNOT9/hRcd1/hCAF40, are also implicated in repression of promoter activity [11] . The major repression function of CNOT2 was found in a conserved protein motif called the NotBox, which is also present at the C-terminus of CNOT3 [11] . Furthermore, the Ccr4-Not complex also plays a direct role in mRNA degradation and aberrant mRNA surveillance (reviewed in [14] ). The deadenylase subunits in the complex are responsible for these events. Ccr4p is the major mRNA deadenylase in yeast [15, 16] , whereas mammalian cells require both CNOT6/hCcr4 and CNOT7/hCAF1 activities for constitutive deadenylation [17] .
The composition of the conserved Ccr4-Not complex has been well studied in yeast. Initially, it was identified as physically and functionally separate subcomplexes of Ccr4-associated proteins and of Not proteins [18] . Not1p/Cdc39p, Not2p/Cdc36p, Not3p, Not4p/Mot2p and Not5p form the Not module, which regulates transcription initiation and elongation (reviewed in [1, 2] ). They were first isolated as repressors of HIS3 gene transcription from a non-canonical TATA element in yeast (reviewed in [10] ). The Ccr4 module encompasses the two deadenylases Ccr4p and Caf1p in association with Caf40p and Caf130p [19, 20] , and is involved in mRNA degradation. Surprisingly, biochemical analyses revealed that the Ccr4 module also binds Not proteins [19, 20] , resulting in the Ccr4-Not protein complex. Interestingly, the Ccr4p subunit affects transcription both negatively and positively [20] . Orthologues for most of the yeast Ccr4-Not components have been identified in human cells [21, 22] . Not3p and Not5p are similar yeast proteins, and the human genome contains only one orthologous protein, CNOT3 [21] . In contrast, two human orthologues have been found for yeast Ccr4p (CNOT6/hCcr4a and CNOT6L/hCcr4b) [23] and for yeast Caf1p (CNOT7/hCAF1 and CNOT8/hPOP2/CALIF) [21] . These four deadenylases have been identified as components of human Ccr4-Not complexes [23, 24] , but the exact composition of the human complex is less well studied.
In the present study, we determine the composition and the interactors of human Ccr4-Not complexes from stable HeLa cell derivatives, which express epitope-tagged Ccr4-Not subunits at near endogenous levels. We identified the interactors of the purified complexes from these cell lines by MS. Strikingly, the CNOT7 and CNOT8 proteins specify the distinct human Ccr4-Not complexes, whereby CNOT6 and CNOT6L associate more tightly with CNOT7 than with CNOT8. Besides the known Ccr4-Not proteins, we invariably and abundantly co-purified TAB182 and C2ORF29 proteins in human Ccr4-Not complexes, indicating that these subunits are novel core complex components. Moreover, our results imply that association of CNOT4 with the Ccr4-Not complex may be a regulated event. Furthermore, additional GO (Gene Ontology) analyses of interactors of the complex suggest direct involvement of CNOT7-containing complexes in mRNA splicing, transport and localization, whereas CNOT8-containing complexes seem to play a role in splicing only. Taken together, the results of the present study support the model wherein Ccr4-Not complexes are involved from RNA synthesis in the nucleus to RNA decay in the cytoplasm.
MATERIALS AND METHODS

Antibodies and immunoblotting
CNOT1, CNOT2 and CNOT3 antibodies have been previously described [13] . Crude serum raised against CNOT8 (described in [21] ) was affinity-purified via immunoblotting against a GST (glutathione transferase)-CNOT8 fusion protein and elution from the membrane using 100 mM glycine/HCl (pH 2.5). Antibodies directed against CNOT7 (clone 2F6), HA (haemagglutinin; clone 3F10), α-tubulin (DM1A) and TAB182 were obtained from Abnova, Roche Applied Science, Calbiochem and Novus Biologicals respectively. The HA (12CA5) antibody was purified from the hybridoma cell line 12CA5 (A.T.T.C.).
Protein complexes or extracts were separated using SDS/PAGE and were then transferred on to PVDF membranes. The membranes were blocked using 5 % (w/v) non-fat dried skimmed milk, probed with primary antibodies overnight at 4
• C and then with HRP (horseradish peroxidase)-conjugated secondary antibodies for 45 min at room temperature (21 • C). Detection was performed by ECL (enhanced chemiluminescence) according to the manufacturer's protocol (PerkinElmer Life and Analytical Sciences).
cDNA sequences of human CNOT genes
Human cDNAs of CNOT1 (partial), CNOT2, CNOT3S, CNOT3L, CNOT4N, CNOT4L, CNOT8 and CNOT9 have been previously described [11, 21] . cDNA sequences of the human CNOT6 ORF (open reading frame) was obtained by PCR using pGal4-hCCR4 [25] as a template. Full-length cDNAs of human CNOT7 and CNOT10 were purchased from RZPD (German Science Centre for Genome Research, Germany). All cDNA constructs were verified by DNA sequencing.
Generation of stable cell lines
Human CNOT cDNAs were introduced by GATEWAY cloning [26] into a retroviral destination plasmid derived from pBABEpuro carrying an N-terminal FlagPreScissionHA-tag (for CNOT2, CNOT3L, CNOT4L, CNOT6, CNOT8, CNOT9 and CNOT10) or a C-terminal HAPreScissionFlag-tag (for CNOT3S and CNOT7). Details of primer sequences and the cloning strategy are available upon request from the corresponding author. HeLa S3 cell clones expressing a tagged CNOT protein were obtained by retroviral transduction and puromycin selection. Positive clonal cell lines were identified by immunoblotting using antibodies directed against HA, CNOT2, CNOT3, CNOT7 or CNOT8. HeLa S3 cells with integrated empty pBABE-puro plasmid served as a control.
Overexpression in HEK (human embryonic kidney)-293T cells
Human CNOT7 and CNOT8 cDNAs were introduced by GATEWAY cloning into pMT2SM carrying an N-terminal HA tag. HEK-293T cells were transfected with 3 μg of pMT2SM-HA-CNOT7 or pMT2SM-HA-CNOT8 using FuGENE TM 6 according to the manufacturer's instructions (Roche Applied Science). Cells were extracted 40 h post-transfection in lysis buffer [20 mM Hepes/NAOH (pH 8.0), 5 % (v/v) glycerol, 150 mM NaCl, 0.5 mM EDTA, 5 mM MgCl 2 , 0.5% (v/v) Nonidet P40, 0.5 mM PMSF, 0.5 mM DTT (dithiothreitol) and Complete TM protease inhibitor cocktail (Roche Applied Science)] and analysed by immunoblotting.
Cell culture conditions
HeLa S3 stable cell lines and HEK-293T cells were grown in DMEM (Dulbecco's modified Eagle's medium; 1 g/l glucose) with 10 % (v/v) FBS (fetal bovine serum), 2 mM L-glutamine and 100 units/ml penicillin/streptomycin (and 1 μg/ml puromycin for HeLa S3 cells). HeLa S3 cells were grown in bioreactors in MEM (modified Eagle's medium with Hank's balanced salt solution), 10 % (v/v) FBS, 2 mM L-glutamine, 1 % 100 × non-essential amino acids, 100 units/ml penicillin/streptomycin and 1 μg/ml puromycin. All reagents were obtained from Cambrex, except for puromycin (Sigma).
Protein extraction and affinity purification
HeLa cells were lysed by douncing in hypotonic lysis buffer [10 mM Hepes/NaOH (pH 8.0), 10 mM KCl, 1.5 mM MgCl 2 , 0.5 mM DTT and 0.5 mM PMSF]. Proteins were extracted in 1/3 volume of 4 × extraction buffer [80 mM Hepes/NaOH (pH 8.0), 50 % (v/v) glycerol, 1.68 M NaCl, 0.8 mM EDTA, 3 mM MgCl 2 , 1 mM DTT and 4 % (v/v) protease inhibitor cocktail (Sigma)], bringing the ionic strength to 420 mM NaCl. Lysates were centrifuged at 168 000 g for 45 min at 4
• C. Supernatants were dialysed overnight against dialysis buffer [20 mM Hepes/NaOH (pH 8.0), 20 % (v/v) glycerol, 100 mM KCl, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTT].
Dialysed extracts (10-20 mg/ml) were incubated for 5 h with 1/20 volume of M2 affinity resin (Sigma) pre-equilibrated in BC150 buffer [40 mM Tris/HCl (pH 7.9), 20 % (v/v) glycerol, 150 mM KCl, 0.2 mM EDTA and 0.1 % (v/v) Nonidet P40]. The resin was subsequently washed with 60 column volumes of BC300 buffer [20 mM Tris/HCl (pH 7.9), 20 % (v/v) glycerol, 300 mM KCl, 0.2 mM EDTA and 0.1 % (v/v) Nonidet P40]. Proteins were eluted twice with two column volumes of BC300 buffer containing 200 μg/ml FLAG peptide (Sigma). FLAG elution fractions were pooled and subsequently incubated overnight with HA affinity resin pre-equilibrated in BC300 buffer. HA affinity resin was prepared by covalently binding HA (12CA5) antibody to Dynabeads protein A (Dynal Biotech) using dimethyl pimelimidate dihydrochloride (Pierce) according to the manufacturer's instructions. After overnight incubation, resin was washed with 15 resin volumes of BC300 buffer. Bait and interacting proteins were eluted for 20 min at 30
• C with 2 mg/ml HA peptide (Sigma-Genosys), followed by precipitation [27] and identification by MS, or proteins were separated on 4-12 % BisTris gels (NuPAGE; Invitrogen) for silver-stain detection.
For affinity purification at lower salt conditions, cells were lysed in hypotonic lysis buffer, dounced and proteins were extracted in 1/3 volume of 4 × extraction buffer containing 600 mM NaCl, bringing the ionic strength to 150 mM NaCl, followed by overnight dialysis. Extracts were purified via the FLAG tag as described above, using buffers containing 150 mM NaCl. Purified complexes were subjected to immunoblotting.
MS/MS
Precipitated Ccr4-Not complexes were dissolved in 8 M urea in 50 mM ammonium bicarbonate (pH 8.0), and were incubated with 1 μg of LysC (Roche Diagnostics) for 4 h at 37
• C. Following reduction and alkylation using 2 mM DTT and 4 mM iodoacetamide respectively, the sample was diluted to 2 M urea with 50 mM ammonium bicarbonate (pH 8.0), and incubated overnight with 2 μg of trypsin at 37
• C. Protein digests were desalted using a small plug of C 18 material (3M Empore C 18 extraction disk) packed into a GELoader Tip in a similar manner as described in [28] . The eluate was dried completely by vacuum centrifugation and subsequently reconstituted in 20 % (v/v) acetonitrile and 0.05 % (v/v) formic acid.
SCX (strong cation exchange) was performed using two Zorbax BioSCX-Series II columns (internal diameter, 0.8 mm; length, 50 mm; particle size, 3. A total number of 24 SCX fractions (1 min each, i.e. a 50 μl elution volume) were manually collected and dried in a vacuum centrifuge. These residues were reconstituted in 20 μl of 0.1 M acetic acid and approximately half of this solution was analysed by on-line nanoflow liquid chromatography FTICR (Fouriertransform ion cyclotron resonance)-MS/MS (tandem MS) as previously described [29] .
Protein identification was processed as described in [29] using IPI (International Protein Index) human (release 3.24, 66921 sequence entries) and Scaffold software package version 2.1 (www.proteomesoftware.com) with a confidence level of 95 % for peptide identification and 99 % for protein identification. Unique peptide counts of the identified Ccr4-Not components are given in Supplementary Table S1 (at http://www.BiochemJ.org/bj/422/bj4220443add.htm). The total number of spectral counts for each component was divided by its mass (in daltons) and converted into NSAFs (normalized spectral abundance factors) as described in [30] .
The data associated with this manuscript may be downloaded from ProteomeCommons.org Tranche (https:// proteomecommons.org/tranche/), using the following Tranche hash:
EKYhwbHIfbis7ocZqc + 18hDwmT7WZvSLAWp1dVKjhB-WF9W2Ubb8IEScvJqhwZMJQMYBpaPAT/HB/yVedmNlPMeNej10cAAAAAAAADPw==. The data can also be downloaded from https://proteomecommons. org/dataset.jsp?i=72595.
Bioinformatics
IPI numbers of identified proteins (by at least two unique peptides, no peptides in a control purification, excluding keratins) were converted into gene symbols using PICR (http://www.ebi.ac.uk/Tools/picr/), DAVID (http://david.abcc. ncifcrf.gov/home.jsp) and UniProt (http://www.uniprot.org/). Some IPI numbers could not be mapped to a gene and were renamed nm_x (non-mapped_x). A list of genes for each purification was submitted to GeneTrail ( [31] ; http://genetrail. bioinf.uni-sb.de/index.php) using all human genes as a reference set. GO term over-representation was assessed using a hypergeometric test with FDR (false discovery rate) adjustment and a significance threshold of 0.05. In addition, a minimum number of two genes per GO term were required for a GO term to be included in the analyses. All statistically significant over-represented GO terms were collected and a matrix was generated consisting of the GO terms and their P values for each of the purifications. P values were transformed to a log 2 scale to reduce the effects of abnormal data distribution during subsequent analyses. Missing values were converted into zero. Matrices containing log 2 -transformed P values of over-represented GO terms were loaded into the clustering module (GenesisWeb) of CARMAweb ( [32] ; https://carmaweb.genome.tugraz.at/carma/) to generate hierarchically clustered heatmaps according to Pearson's correlation. The HomoMINT database (http://mint.bio. uniroma2.it/HomoMINT/Welcome.do; download date 10 June 2009) was used to obtain interologues.
Yeast two-hybrid analysis
The pSH18-34 plasmid, pJG4-5 and pEG202-NLS vectors, B42-CNOT1C, B42-CNOT2, B42-CNOT4N and B42-CNOT8 (B42-CALIF) have been previously described [12, 21] . Other yeast plasmids were created using full-length cDNA sequences of human CNOT proteins, except for B42-CNOT7. This latter construct was obtained by insertion of a murine CNOT7 fragment into pJG4-5, derived from pGal4-mCAF1 [33] containing an extended N-terminal part of 11 amino acids and a point mutation to resemble human protein sequences. Details on the cloning strategy are available upon request from the corresponding author. Yeast strain EGY48 [MATa his3 trp1 ura3 LEU2::pLexAop (× 6)-LEU2] was used for the present assay [21] . Interactions were visualized on X-Gal (5-bromo-4-chloro-3-indolyl-β-Dgalactopyranoside)-containing plates at 30
• C.
Gel filtration
Cell extracts of the CNOT4L-tagged HeLa S3 stable cell line were prepared as described above with the following adaptations: hypotonic lysis buffer also contained 2 % (v/v) protease inhibitor cocktail (Sigma), cells were lysed by syringe douncing and proteins were extracted by addition of 1 vol. of extraction buffer [20 mM Hepes/NaOH (pH 8.0), 20 % (v/v) glycerol, 300 mM NaCl, 0.4 mM EDTA, 1.5 mM MgCl 2 , 0.2% (v/v) Nonidet P40 and 0.5 mM DTT]. Extracts were analysed on a Superose 6 HR 10/30 column (GE Healthcare) in 20 mM Hepes/NaOH (pH 7.9 at 4 • C), 150 mM NaCl, 10 μM ZnCl 2 , 1 mM DTT, 0.5 mM PMSF, 1 μg/ml leupeptin, 1 μg/ml aprotinin and 1 μg/ml pepstatin A, followed by immunoblot analyses of the 0.4 ml fractions.
RESULTS
Stable HeLa S3 cell lines with FLAG-/HA-tagged CNOT proteins under endogenous conditions
The human Ccr4-Not complex is biochemically less well defined than its yeast counterpart [18, 23, 24] . To obtain more insight into the composition of the human complex, we generated HeLa cell lines that stably expressed FLAG-/HA-tagged versions of human CNOT (Ccr4-Not subunits). The expression levels of these tagged proteins within the distinct cell lines were similar with the exception of the more highly expressed CNOT9 ( Figure 1A ). Immunoblot analyses using specific antibodies against CNOT2, CNOT7 or CNOT8 showed near endogenous expression levels of the tagged protein ( Figure 1B) . Immunoprecipitation of tagged CNOT3 or CNOT9 resulted in co-purification of the known subunits of the Ccr4-Not complex, such as CNOT2, CNOT3 and CNOT7 ( Figure 1C ), indicating that the tagged proteins were integrated into larger protein complexes. Notably, similar amounts of CNOT2 and CNOT7 could be co-immunoprecipitated from cell extracts containing tagged CNOT3L or the higher expressed tagged CNOT9 ( Figures 1A and 1C ). This indicated that the higher expression levels of CNOT9 did not disrupt normal Ccr4-Not complex formation. In addition, silver-stain analysis of large-scale affinity purifications of CNOT3L, CNOT7 and CNOT9 cell lines revealed co-purification of other proteins, which were identified as Ccr4-Not complex subunits by MS ( Figure 1D and Table 1 ). Thus the generated HeLa S3 cell lines expressed their epitopetagged proteins at near endogenous levels and were integrated into endogenous Ccr4-Not complexes.
Human Ccr4-Not complexes differ in deadenylase subunits
To analyse the composition of human Ccr4-Not complexes from different entry points, tagged HeLa S3 cells were grown in bioreactors for large-scale affinity purifications of Ccr4-Not complexes, which were subjected to in-solution tryptic digestion, SCX fractionation and nano-reversed phase liquid chromatography coupled to high-resolution MS [LTQ (linear ion trap)-FTICR] analyses. Table 1 summarizes the results in NSAFs to indicate the relative abundances of co-purified proteins among the individual CNOT purifications [30] (Supplementary Figure  S1 , at http://www.BiochemJ.org/bj/422/bj4220443add.htm, is a coloured representation of Table 1 ). In the present study, we define a core subunit of the Ccr4-Not complex as being identified by MS with at least an NSAF value of 0.4 in all Ccr4-Not purifications and with no peptides in a control purification. We define a subunit as variable when the NSAF value is at least 0.4, but not in all purifications. According to these criteria, the deadenylases CNOT6, CNOT6L, CNOT7 and CNOT8 are variable subunits within the human complex and CNOT4 E3 ligase is not an integral subunit of human Ccr4-Not (Table 1) . CNOT1, CNOT2, CNOT3, CNOT9, CNOT10 and the new interactors TAB182 and C2ORF29 were identified as core subunits of the human complexes (Table 1 ). The C2ORF29 protein is predicted Table 1 NSAFs of identified Ccr4-Not components FLAG/HA affinity-purified complexes of a tagged Ccr4-Not subunit were analysed by MS. The control is a HeLa S3 cell line stably transfected with pBABE-puro. Numbers represent 10-fold NSAFs (as described in [30] ) for identified proteins. The molecular masses (kDa) of these interactors are given in the right-hand column. The sum of unique peptides and sum of all identified peptides of identified proteins per purification are shown. Bold numbers indicate the NSAF values of deadenylase subunits in the purified Ccr4-Not complexes using a tagged deadenylase. from the human genome sequence with no known function and TAB182 has been described as a binding protein for tankyrase 1, which plays a role in telomere length and mitotic spindle composition [34, 35] . Immunoblot analysis showed that a small, but significant, proportion of cellular TAB182 co-purified with CNOT3L and CNOT9 complexes ( Figure 1E ), confirming that TAB182 is a stable interactor of the human Ccr4-Not complex. Unfortunately, no antibodies against C2ORF29 are available, precluding confirmation by Western blot analysis. The detailed MS results revealed several interesting properties of human Ccr4-Not complexes (Table 1 ). In particular, the variable deadenylase subunits showed interesting differences among the tagged CNOT6, CNOT7 and CNOT8 purifications (shown in bold in Table 1 ). No significant CNOT7 was detected in CNOT8 purifications and vice versa, suggesting that CNOT7 and CNOT8 are present in distinct Ccr4-Not complexes. CNOT6 and CNOT6L were identified in CNOT7 purifications, whereas they were absent from CNOT8 purifications, suggesting that CNOT6/6L proteins stably interact with CNOT7, but not with CNOT8. No CNOT6L could be identified in two CNOT6 purifications (Table 1 and the Tranche database), indicating mutual exclusiveness of these subunits as expected from their distinct functions; CNOT6L, but not CNOT6, impairs cell growth [23] . It is interesting to note that the deadenylases CNOT6, CNOT6L, CNOT7 and CNOT8 are relatively lower represented in the purifications than the other CNOT proteins, except when they are the bait of the purification. Moreover, the deadenylase subunits could not be detected in CNOT10-purified complexes. This could, however, be due to the lower amounts of recovered proteins in this purification. Importantly, Ccr4-Not complexes obtained via other tagged subunits inversely identified CNOT10. Furthermore, comparison of full-length CNOT3L (residues 1-753) to CNOT3S lacking the Not-Box (residues 1-609) showed that the smaller isoform did not interact with any Ccr4-Not subunit. This indicates that the NotBox is required for the stable interaction of CNOT3 with the rest of the complex [11, 21, 36] . Finally, human CNOT4 could hardly be detected in purified Ccr4-Not complexes in contrast with yeast [18, 20] , indicating that CNOT4 is not stably integrated within human complexes. In conclusion, purified Ccr4-Not complexes from human cells using seven different entry points indicate the existence of several Ccr4-Not complexes differing only in the deadenylase subunits CNOT6, CNOT6L, CNOT7 and CNOT8.
Analyses of substoichiometric interactors suggest Ccr4-Not functioning in RNA splicing and nuclear export
Besides subunits of Ccr4-Not complexes, the MS results identified 498 proteins with at least two unique peptides and no peptides in a control purification. These proteins have low NSAF values and are not present in all purifications. We propose that these 498 proteins represent substoichiometric interactors of tagged Ccr4-Not proteins (Supplementary Table S2 at http://www.BiochemJ.org/bj/422/bj4220443add.htm). Approx. 47 % of these associated proteins were shared among the deadenylase subunits and the other CNOT proteins, indicating that almost half of them bind both the deadenylases as well as transcriptional Ccr4-Not subunits. In addition, 70 % of the interactors were co-purified by at least two CNOT proteins, 44 % by at least three Ccr4-Not components, and 26 % by at least four subunits. Importantly, these proteins were not identified in a control purification, suggesting that these substoichiometric interactors are relevant for the function of the Ccr4-Not complex. We searched the HomoMINT database [37] for interologues to find seven interactors shared between our MS/MS-based human dataset and the yeast dataset. These shared interologues are rather diverse in function and we found only a few peptides of each interactor (Supplementary Table S3 at http://www.BiochemJ.org/bj/422/bj4220443add.htm).
To gain insight into the biological functions of human Ccr4-Not complexes, GO term over-representation analyses were performed with the CNOT subunits and the substoichiometric Ccr4-Not interactors. The results are given in Supplementary Figure S2 (at http://www.BiochemJ.org/bj/422/bj4220443add.htm) of which the interesting clusters are represented in Figure 2 . Clusters containing gene transcription and RNA stability-related terms were identified (Figures 2A and 2B ), indicating that expected functions of Ccr4-Not can be retrieved from these data analyses. Interestingly, many subunits gave association with mRNA splicing (Figure 2C) , and mRNA transport and localization ( Figure 2D ), except for CNOT6 and CNOT8 respectively. Moreover, CNOT6, CNOT8 and CNOT10 have low probability to interact with the nuclear envelope (Figures 2E and 2F) , suggesting that these proteins may not be involved directly in nuclear mRNA export. Most Ccr4-Not subunits co-purified NUPs (nuclear pore complex proteins) located at the nuclear basket, the cytosolic filaments and inside the nuclear membrane (Supplementary Figure S3 at http://www. BiochemJ.org/bj/422/bj4220443add.htm). The majority of the NUPs inside the nuclear membrane were co-purified. However, more peptides were retrieved from the identification of NUPs on the cytosolic or nuclear membrane side (Supplementary Figure  S3) . This suggests that the Ccr4-Not complex may interact with the intact nuclear pore complex. Thus GO term overrepresentation of substoichiometric interactors indicates physical interactions of human Ccr4-Not complexes with proteins involved in mRNA processing and nuclear export, suggesting involvement of Ccr4-Not in these cellular processes.
CNOT1 binds CNOT4, and CNOT6 binds CNOT8 in yeast two-hybrid assays
To further explore the composition of human Ccr4-Not complexes, we investigated binary interactions between known components of the complex by yeast two-hybrid interaction experiments [38] . Instead of using full-length CNOT1 protein, this large protein (2376 residues) was split up into smaller fragments ( Figure 3A) . Positive binary interactions between a B42-fusion and a LexA-fusion CNOT protein in yeast are shown in Figure 3(B) . The majority of the subunits, except for CNOT3L and CNOT6, interacted with the C-terminal part of CNOT1 (CNOT1L: residues 648-2376). This is in concordance with earlier findings that a shorter C-terminal CNOT1 (CNOT1C: residues 1106-2376) interacts with CNOT2, CNOT4N and CNOT8 [21] . In addition, CNOT2 and CNOT9 interacted with the N-terminus of CNOT1 (CNOT1N: residues 1-716). These observations indicate a scaffold function for CNOT1 as suggested previously for its yeast orthologue Not1p [18] . Moreover, none of the examined subunits interacted with themselves, suggesting that they occur as monomers. Interestingly, CNOT3L only interacted with CNOT2 ( Figure 3B ), suggesting that CNOT3 integrates within the Ccr4-Not complex by CNOT2 interaction. Furthermore, CNOT6 interacted with CNOT7 and vice versa. Also, CNOT6 showed a binary interaction with CNOT8 in this assay, whereby the reciprocal interaction could not be performed owing to selfactivation properties of LexA-CNOT8. It is interesting to note that CNOT4N and CNOT1L also interacted in this assay.
CNOT4 resides in a smaller complex outside the human Ccr4-Not complex
To further investigate the association of CNOT4 with the Ccr4-Not complex, we have generated a cell line that stably expresses the largest isoform of CNOT4, CNOT4L [21] . Extracts of these cells were separated by gel filtration under physiological salt conditions and were subjected to immunoblot analyses (Figure 4) . Tagged CNOT4L protein resided in a ∼ 200 kDa complex, whereas the subunits CNOT1, CNOT3, CNOT7 and CNOT8 coeluted in fractions corresponding to ∼ 1.2 MDa. In addition, a small fraction of CNOT8 and of CNOT2 was seen at a single protein size (results not shown). It would be interesting to determine the composition of the ∼ 200 kDa complex. However, the low abundance of this complex precluded our first attempts in this direction (results not shown).
Taken together, gel-filtration analyses confirm the MS results that CNOT4 is not stably interacting with human Ccr4-Not components, but rather forms a distinct protein complex in human cells. The identity of CNOT4-associated subunits could reveal how interaction of CNOT4 with the Ccr4-Not complex would be regulated.
CNOT6 interacts more strongly with CNOT7 than with CNOT8
To further analyse the interactions among the four human deadenylases, we first determined the specificity of antibodies directed against CNOT7 or against CNOT8 as these deadenylases are 75 % identical in their primary structure. Upon transient overexpression of CNOT7 and/or CNOT8, the CNOT7 antibodies specifically recognized CNOT7 ( Figure 5A , upper left-hand panel), whereas antibodies directed at CNOT8 (middle lefthand panel) detected both CNOT7 (upper band) and CNOT8 (lower band). The CNOT7 antibodies also specifically recognized endogenous CNOT7 ( Figure 5A , upper right-hand panel), whereas the CNOT8 antibodies detected endogenous CNOT8, but also displayed considerable background bands ( Figure 5A , middle right-hand panel). Thus the specificity of CNOT7 antibodies is exclusive for CNOT7 proteins, and antibodies directed against CNOT8 detect both CNOT7 and CNOT8 subunits, which can be distinguished by different mobilities in protein gels.
Immunoblot analyses using these antibodies showed the absence of CNOT7 proteins in CNOT8-purified complexes, and no CNOT8 proteins could be detected in CNOT6-and CNOT7-purified complexes ( Figure 5B ). As expected, both CNOT7 and CNOT8 were present in CNOT2-purified complexes ( Figure 5B ). These observations confirm the MS results (Table 1  and Supplementary Table S1 ) of the mutual exclusiveness of CNOT7 and CNOT8 within Ccr4-Not complexes. In addition, the interaction between CNOT6 and CNOT8 was further studied by immunoblot analyses using the described antibodies ( Figure 5C ). Yeast two-hybrid analysis showed CNOT6 binding to CNOT8, whereas MS results did not reveal CNOT6 in CNOT8 complexes and vice versa (Table 1 and Supplementary Table S1 ). One possibility is the loss of the CNOT6-CNOT8 interaction during the two-step purification prior to MS identification. To address this hypothesis, one-step FLAG purifications of Ccr4-Not complexes were performed under low-or high-salt concentrations ( Figure 5C ). The association of CNOT7 within CNOT6-or CNOT2-purified complexes was not sensitive to salt, indicating strong binding of CNOT7 to these complexes. Notably, CNOT8 could be detected just above background in CNOT6-purified complexes under low-salt conditions only, whereas CNOT8 was clearly detectable in CNOT2-purified complexes independent of the salt concentration. Taken together, this indicates that the interaction between CNOT6 and CNOT8 is sensitive to the salt concentration. Unfortunately, the lack of CNOT6 antibodies does not allow us to perform the converse experiment using CNOT7-and CNOT8-purified complexes. In conclusion, these experiments confirm that CNOT7 and CNOT8 deadenylases are mutually exclusive subunits of human Ccr4-Not complexes, whereby CNOT6 seems to interact less stably with CNOT8 than with CNOT7.
DISCUSSION
In the present study, we have investigated the composition and the protein interactors of human Ccr4-Not complexes by an in-depth proteomic effort. We have defined the core proteins of human Ccr4-Not complexes including two new subunits, TAB182 and C2ORF29. These complexes are heterogeneous in composition by their associated mRNA deadenylase subunits, which may reflect functional differences in coupling mRNA synthesis and processing to nuclear export. Size-fractionation experiments showed that the human CNOT4 E3 ligase resides in a separate ∼ 200 kDa protein complex. Interestingly, a yeast twohybrid assay displayed a CNOT4 interaction with the scaffold protein CNOT1. Moreover, CNOT3 requires its Not-Box to integrate into the human Ccr4-Not complex via CNOT2. Taken together, the results of the present study define the composition of human Ccr4-Not complexes and have revealed the co-existence of multiple Ccr4-Not complexes differing in their deadenylase subunits.
Defining the human Ccr4-Not complexes
In the past, the components and the composition of the yeast Ccr4-Not complex have been revealed by a variety of biochemical purifications and genetic experiments [18] [19] [20] . Gel filtration of the yeast complex revealed two peaks of 1.9 and 1.0 MDa [18, 19] . In contrast, we observed a rather broad peak for the human complex at ∼ 1.2 MDa (Figure 4) . Gavin et al. [39] have purified the human Ccr4-Not complex via a TAP-tagged version of CNOT2, but they failed to identify CNOT3, CNOT4 and CNOT6L as Ccr4-Not components. Our MS results indicate a core of seven subunits for human Ccr4-Not complexes consisting of CNOT1, CNOT2, CNOT3, CNOT9, CNOT10, TAB182 and C2ORF29 with the associated deadenylases CNOT6, CNOT6L, CNOT7 and CNOT8 ( Figure 6 ). The combined molecular mass of these components in the human complex is ∼ 0.9 MDa, which corresponds with the gel-filtration results (Figure 4) .
The overall composition of human Ccr4-Not complexes is similar to the yeast complex [19] . We found that several CNOT proteins (CNOT2, CNOT7, CNOT8 and CNOT9) interact with the largest subunit of the complex, CNOT1 (Figure 3B ), indicating that this protein acts as a scaffold similar to yeast Not1p. However, we noted several differences between the human and yeast Ccr4-Not complexes. First, human cells contain multiple deadenylases, which have different binding properties. Our salt titration experiments indicate that CNOT6 interacted less stably with CNOT8 compared with CNOT7 ( Figure 5C ). Notably, CNOT6 only showed binary interactions with CNOT7 and CNOT8 in a yeast two-hybrid assay ( Figure 3B ), indicating that these two deadenylases link CNOT6 to the rest of the Ccr4-Not complex as proposed in [21, 40] . Secondly, CNOT3 did not bind directly to CNOT1 as reported for the yeast Ccr4-Not complex [18, 19] , but it did bind CNOT2 ( Figure 3B ). Moreover, MS analyses showed that CNOT3 lacking the Not-Box (CNOT3S) could not interact with any Ccr4-Not subunits (Table 1) . This suggests that CNOT3 integrates in the human complex via a Not-Box-mediated interaction with CNOT2. Finally, in contrast with yeast Not4p [18, 19] , CNOT4 was not stably integrated in human Ccr4-Not complexes (Table 1 and Figure 4 ), but it could interact with the scaffold protein CNOT1 in a yeast two-hybrid assay ( Figure 3B ). In addition, human CNOT4 is a true orthologue of yeast NOT4 as it can complement not4Δ not5Δ lethality in yeast [21] . This suggests that the CNOT4 interaction with the Ccr4-Not complex may be a regulated event in human cells. Possibly, association of a core subunit precludes interaction of CNOT4 with CNOT1. It is also possible that interactors of CNOT4 or post-translational modifications are involved in restricting CNOT4 integration into the human complex. A model of the distinct Ccr4-Not complexes in human cells is depicted in Figure 6 .
Multiple human Ccr4-Not complexes differing in mRNA deadenylase subunits
The yeast Ccr4-Not complex harbours two deadenylases, Ccr4p and Caf1p, of which Caf1p is dispensable for Ccr4p deadenylase activity [15, 16] . Human cells contain two orthologues of yeast Ccr4p, CNOT6/hCcr4a and the recently identified CNOT6L/hCcr4b, and two homologous Caf1p orthologues, CNOT7 and CNOT8. All of these Ccr4p/Caf1p orthologues display in vitro 3 →5 poly(A) exoribonuclease activity [23, 41] . The results of the present study revealed that the highly homologous CNOT7 and CNOT8 proteins are in separate complexes (Table 1 and Figure 5B) . Only a small portion of CNOT8-containing complexes harbour CNOT6, which seems to be less stable than the CNOT6 interaction in CNOT7-containing complexes ( Figure 5C ). It is plausible that CNOT7 and CNOT8 are competing for the same binding site on CNOT1 allowing association of either CNOT7 or CNOT8. In addition, CNOT6 and CNOT6L may also be mutually exclusive as no unique peptides of CNOT6L were found in two purifications of CNOT6-tagged complexes (Table 1 and the Tranche database). This is also supported by earlier results showing that CNOT6L is functionally distinct from CNOT6 [23] . Furthermore, our results showed copurification of CNOT6-CNOT7 and CNOT6L-CNOT7 (Table 1) , which was previously reported in a transient overexpression approach [40] . Thus all of these findings support a model of distinct Ccr4-Not complexes allowing only a single Ccr4p and a single Caf1p orthologue ( Figure 6 ). It is interesting to note that the substrate specificity for the enzymatic activity of CNOT7 and CNOT8 is different [41] , which may allow differential regulation of mRNA degradation.
Human Ccr4-Not complexes play various roles in mRNA synthesis to degradation GO term over-representation analyses of associated Ccr4-Not proteins provided insights into the functional roles of human Ccr4-Not complexes such as in gene transcription and RNA stability (Figures 2A and 2B) . A role in mRNA transport and localization has also been indicated for CNOT7-, but not for CNOT8-, containing complexes ( Figures 2D-2F) . Indeed, multiple NUPs interacted with all CNOT proteins tested, except for CNOT8 (Supplementary Figure S3) . Interestingly, CNOT6 and CNOT7 proteins were reported to shuttle between the nucleus and cytoplasm [40] . In general, more peptides were retrieved from nuclear and cytosolic NUPs than for NUPs within the nuclear envelope (Supplementary Figure S3) . This may indicate a shuttling function of the Ccr4-Not complex, which may link its nuclear and cytosolic functions. In addition, involvement in mRNA splicing is also suggested by GO term over-representation analyses, which included the CNOT8-containing complexes ( Figure 2C ). Taken together, these findings support the view that human Ccr4-Not complexes can influence the mRNA metabolism at multiple levels.
In conclusion, the present study provides comprehensive composition analyses of Ccr4-Not complexes in human cells. We identified multiple Ccr4-Not complexes differing in their deadenylase subunits and in complex stability. Our proteomic analyses provide a platform for further functional studies of human Ccr4-Not complexes defining the regulation of mRNA metabolism by this evolutionarily conserved protein complex.
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Table S2 Identified proteins in Ccr4-Not complex purifications
Interactors of tagged CNOT proteins, identified by at least two unique peptides and no peptides in a control purification, are shown in the Table by their gene names. The core and variable Ccr4-Not subunits are given in bold. The entry points for the purifications are indicated on the top. The peptide counts (unique and total), identified peptide sequences and protein identifiers can be downloaded from ProteomeCommons.org Tranche (https://proteomecommons.org/tranche/), using the following Tranche hash: EKYhwbHIfbis7ocZqc + 18hDwmT7WZvSLAWp1dVKjhBWF9W2Ubb8IEScvJqhwZMJQMYBpaPAT/HB/yVedmNlPMeNej10cAAAAAAAADPw==. The data can also be downloaded from https://proteomecommons.org/ dataset.jsp?i=72595. Tagged protein  CNOT2  CNOT3L  CNOT6  CNOT7  CNOT8  CNOT9  CNOT10  CNOT35   CNOT1  CNOT1  CNOT1  CNOT1  CNOT1  CNOT1  CNOT1  CNOT3  CNOT2  CNOT2  CNOT2  CNOT2  CNOT2  CNOT2  CNOT2  ALDOA  CNOT3  CNOT3  CNOT3  CNOT3  CNOT3  CNOT3  CNOT3  BAT2D1  CNOT6L  CNOT4  CNOT6  CNOT6  CNOT8  CNOT4 ACIN1  ABHD14B  ANKHD1  ALDOA  CLTB  ACTL6A  C1ORF77  DDX46  ACTL6A  ACIN1  ANLN  ANKRD17  CSTF2  AIP  CAPG  FLJ78261  AHSA1  ACTL6A  ARHGEF2  ANLN  DDX46  AKAP8  CCT2  GCN1L1  AIP  AHCTF1P  ASCC3L1  API5  DHX15  AKAP8L  CCT4  HNRPF  AK1  AHSA1  BAT2D1  APPL  DNAJA1  ALDOA  CCT5  HNRPU  AKAP13  AKAP8  CAPG  ARCN1  EFTUD2  AOF2  CCT6A  MKI67  AKAP8  AKAP8L  CCT2  ARFGAP2  FHL3  API5  CCT8  MYH9  ANAPC1  ALDOA  CCT3  ARHGAP1  GAPDH  ARCN1  CDKN2AIP  NUP153  ANKRD17  ANKHD1  CCT4  ARHGEF7  GPBP1L1  ARFGAP2  CFL1  NUP214  ANXA7  ANKRD17  CCT6A  ASCC3L1  HNRPAB  ARHGAP1  CLTB  PABPC1  API5  AOF2  CCT7  BAG2  HNRPU  ATXN7L3  CNN2  PHGDH  APPL  AP1GBP1  CCT8  BAG4  IGF2BP3  BAG2  COPA  PPIAP19  ARCN1  API5  CDKN2AIP  BAT2D1  LSM3  BAG4  CPSF3  PPP1R12A  ARFGAP2  APPL  CKAP5  BAT3  M6PRBP1  BAT1  CTNNA1  PRKAR2A  ARHGAP1  ARCN1  COPZ1  BTG3  MYH9  BUB3  DAB2  RANBP2  ARHGEF1  ARFGAP2  DDX46  BUB3  MYO1C  C19ORF21  DDB1  RFC1  ARHGEF2  ARHGAP1  DIAPH1  C1ORF35  MYO1E  C1ORF77  DDX46  RPS27A  ARHGEF7  ARHGEF2  EIF4A1  C1ORF77  MYO6  C22orf28  DNAJA1  SFRS2IP  ASCC3L1  ARHGEF7  ELAVL1  C9ORF88  PABPN1  CALU  DYNC1H1  SH3GL1  ATG3  BAG2  FLJ78261  CACYBP  PCNP  CAPG  EFTUD2  SMC4L1  BAG2  BAG4  FUBP3  CALU  PKP1  CAPZA2  EIF4A1  SNX12  BAT1  BAT1  GCN1L1  CCT2  PLAT  CCT2  ELAVL1  STRAP  BAT2D1  BAT2D1  HDAC1  CCT3  PNN  CCT3  ENO1  TKT  BAT3  BAT3  HDLBP  CCT4  PPIAP19  CCT4  FAM50A  TLN1  BRD4  BRD4  HNRPU  CCT5  PRMT5  CCT5  FLJ78261  TPX2  BRRN1  BRRN1  IQGAP1  CCT6A  PUF60  CCT6A  FLNA  UBA6  BRWD2  BTG3  JMJD1B  CCT7  RNF219  CCT7  FUBP1  VCL  BUB3  BUB3  KCNB2  CCT8  RPS27A  CDC37  GAPDH  VIM  C19ORF21  C19ORF21  KIAA0460  CDC42EP4  S100A7  CDC42EP4  HDLBP  WNK1  C1ORF35  C1ORF77  KIAA1967  CDK5RAP2  S100A8  CHMP2A  HNRNPUL2  YY1  C9ORF88  C22orf28  MAGED2  CDKN2AIP  SART1  CHMP4B  HNRPU  CACYBP  C4ORF8  MAP2K2  CENPE  SEH1L  CIAO1  HSP90B1  CAD  CAD  MAP4  CEP55  SERPINB3  CLTB  IGF2BP3  CAND1  CAPG  MKI67  CHMP2A  SF3B2  CNN2  IQGAP1  CAPG  CAPZA2  MYPN  CIAO1  SNW1  CPSF3  KIAA1967  CAPZA2  CBX8  NBN  CKAP5  SNX12  CRTC3  MAP4  CCT2  CCT2  nm_43  CLASP2  SUMO1  CSTF2  MYH9  CCT3  CCT3  NUMA1  CNN2  TCF3  CUGBP1  MYO1E  CCT4  CCT4  NUP153  COG7  TPM1  DAB2  MYO6  CCT5  CCT5  NUP214  COPA  TPM4  DDX46  NBN  CCT6A  CCT6A  PHGDH  COPE  U2AF2  DDX48  NUP214  CCT7  CCT7  PPP1R12A  COPZ1  YTHDF1  DIDO1  ORC2L  CCT8  CCT8  PRDX1  CPSF3 DMAP1 PABPC1
Figure S2 GO term over-representation of Ccr4-Not interactors
All interactors identified by at least two unique peptides and no peptides in a control purification (keratins excluded) were analysed for GO term over-representation. Heatmap is presented in two parts in colours that represent log 2 P values of Pearson correlation clustering multiplied by −1 on a scale of 0-35. Selected clusters are highlighted in Figure 2 . CNOT2  CNOT3L  CNOT6  CNOT7  CNOT8  CNOT9  CNOT10  CNOT35   CD2BP2  CDC42EP4  PUM1  CRNKL1  DNAJA1  PAK2  CDC37  CDK5RAP2  QKI  CSTF2  DNAJB1  PARP1  CDC42EP4  CDKN2AIP  RACGAP1  CTNNA1  DVL2  PFN1  CDK5RAP2  CENPE  RAD23B  DDX19A  DYNLRB1  PGK1  CDKN2AIP  CEP170  RANBP2  DDX48  EIF3S4  PHGDH  CEP170  CFL1  RBMS2  DHX15  EIF4A1  PNN  CKAP5  CHMP2A  RFC1  DIAPH1  ELAVL1  POLDIP3  CLASP2  CIAO1  RFC4  DIDO1  ENO1  POLR3F  COBRA1  CKAP5  RIF1  DNAJA1  ENTH  PPP1R12A  COG7  CNN2  RNF219  DNM1L  EPB41L2  PRCC  COPA  COBRA1  RNPC2  DNM2  FAM50A  PRKAR2A  COPE  COPA  RPL4  DVL2  FEN1  PTTG1  COPG  COPE  SERBP1  DYNC1H1  FHL3  RAD23B  CPSF3  COPZ1  SMC1L1  EHBP1L1  FLJ11806  RBM10  CRNKL1  CRTC3  SMC2  EIF4A1  FLJ78261  RBM17  CSPG6  CRY1  SMC4L1  EIF4G1  FUBP1  RNF219  CTNNA1  CSNK2B  SRP54  ELAVL1  FUBP3  RNPC2  CYLN2  CSPG6  STRAP  ENO1  G3BP  SART1  DAB2  CSTF2  TBL1XR1  FEN1  GAPDH  SCYL2  DARS  CTNNA1  TLN1  FHL3  GATAD2B  SH3GL1  DCTN1  CUGBP1  TPX2  FLJ78261  GBL  SNW1  DDB1  CXXC1  TTK  FUBP1  GGNBP2  SNX12  DDX19A  DAB2  UBA6  FUBP3  GPBP1  SRP72  DDX42  DAZAP1/MEF2D fusion  VIM  G3BP  GPBP1L1  STMN2  DDX46  DDX19A  WNK1  GAPDH  GPKOW  STRAP  DDX48  DDX46  YY1  GAPVD1  GPR177  SYMPK  DHX15  DDX48  ZC3H11A  GATAD2B  HDAC1  TBL1XR1  DIAPH1  DHX15  ZC3HC1  GBF1  HDLBP  TCEB2  DIDO1  DIAPH1  ZNF638  GCN1L1  HNRNPUL2  TCP1  DLG1  DIDO1  HDLBP  HNRPA0  TKT  DNAJA1  DKFZP686L1814  HELLS  HNRPAB  TLN1  DNAJB1  DLG1  HNRPF  HNRPF  TPD52L2  DNM1L  DMAP1  HNRPLL  HNRPR  TPR  DNM2  DNAJA1  IGF2BP3  HNRPU  UBAP2L  DVL2  DNAJB1  IQGAP1  HRB  UPF1  DYNC1H1  DNM1L  KCNB2  HSP90B1  VCL  EDC4  DNM2  KIAA1967  IGF2BP1  VIM  EFTUD2  DVL2  KPNA4  IGF2BP3  YTHDF1  EHBP1L1  DYNC1H1  KPNA6  KHSRP  YWHAQ  EIF3F  EEF2  KTI12  KIAA1458  YY1  EIF3S4  EIF3S4  LDHA  KIAA1967  ZNF326  EIF3S8  EIF4A1  LRRC40  KPNA4  ZNF830  EIF4A1  EIF4G1  M6PRBP1  KPNA6  EIF4G1  ELAVL1  MAGED2  LIMS1  ELAVL1  ELF1  MAP2K1  LSM1  EPRS  ENO1  MAP2K2  LSM14A  EXOC4  ENTH  MAP4  LSM14B  FAM21B  EPB41L2  MAP4K4  LSM3  FASN  FAM21B  MBNL1  M6PRBP1  FEN1  FAM44A  MINK1  MAD1L1  FKBP15  FAM50A  MKI67  MAP2K2  FLJ11806  FEN1  MLH1  MAP4  FLJ78261  FHL3  MTA2  MAP7D3  FLNA  FKBP15  MYH9  MAX  FOXK1  FLJ10404  NACA  MBNL1  FUBP3  FLJ11806  NBN  MIB1  G3BP  FLJ78261  nm_43  MYH9  GAPVD1  FLNA  NUDC  NACA  GATAD2B  FOXK1  NUMA1  NBN  GBF1  FUBP1  NUP153  NCOA5  GCN1L1  FUBP3  NUP214  NFATC2IP  GPKOW  G3BP  OAS3  NOL7  HCAP-G  GAPDH  OXSR1  NONO  HDLBP  GAPVD1  PARP1  NUDC  HELLS  GATAD2B  PGK1  NUP54  HNRPAB  GBL  PHGDH  OXSR1  HNRPF  GCN1L1  PICALM  PABPC1  HNRPL  GGNBP2  PKM2  PABPN1  HNRPLL  GPBP1  PKP3  PCNP SERBP1  S100A7  NBN  MAP4K4  SERPINB3  S100A8  NCOA5  MAP7D3  SF3B1  SAP30  NDRG3  MAX  SFRS2IP  SART1  NEK9  MBNL1  SH3GL1  SEC13  NFATC2IP  MIB1  SHC1  SEH1L  NHN1  MINK1  SMARCA5  SEPTIN 9  NKRF  MKI67  SMC4L1  SERBP1  nm_43  MLH1  SNX12  SERPINB3  NONO  MRE11A  SNX2  SF3A1  NR3C1  MTA2  SP1  SF3B2  NRBP1  MYH9  SRFBP1  SF3B3  NSUN2  MYO1E  STMN2  SFRS2IP  NUDC  MYPN  STRAP  SH3GL1  NUMA1  NACA  TANC1  SH3GLB2  NUP107  NBN  TARDBP  SHC1  NUP160  NCOA5  TCF3  SLU7  ORC2L  NCOR1  TCP1  SMC1L1  OXSR1  NFATC2IP  TIAL1  SNRP70  PABPC1  NHN1  TJP2  SNRPB  PAK2  nm_43  TLN1  SNRPD2  PARP1  NOL7  TMPO  SNW1  PARP4  NONO  TNRC15  SNX12  PDCD6IP  NUDC  TPI1  SORBS2  PGK1  NUMA1  TPR  SP1  PHGDH  NUP153  TRAFD1  SRFBP1  PKN1  NUP214  TRIP13  SRP54  PKN2  NUP54  TSSC1  SRP72  PKP3  ORC2L  TUBA4A  SSBP1  PLAT  OXSR1  U2AF2  STAM2  PNN  PABPC1  UBA6  STRAP  PPP2R1A  PAK2  UBAP2  SUMO1 Table S2 (Continued)   Tagged protein  CNOT2  CNOT3L  CNOT6  CNOT7  CNOT8  CNOT9  CNOT10  CNOT35   PPP4R1  PCNP  UBAP2L  TARDBP  PRDX1  PCYT1B  UBE2M  TBL1XR1  PRIM2A  PGK1  UBE2S  TCEB1  PRKAR2A  PHGDH  USP10  TCEB2  PRPF19  PIH1D1  VCL  TCF3  PRPF31  PKM2  VDP  TIAL1  PSMA5  PKP3  VIM  TJP1  PSMC6  PLAT  WDR48  TJP2  PSMD4  PLEKHA6  WNK1  TLN1  PUM1  PNN  XPO1  TMPO  RAB14  POLDIP3  YAF2  TNNI2  RAB6IP2  POLR1C  YLPM1  TNRC15  RACGAP1  POLR2E  YTHDF1  TOB1  RAD50  POLR3D  ZC3HAV1  TOB2  RANBP2  POLR3E  ZC3HC1  TPD52L2  RANBP5  POLR3F  TPI1  RARS  PPIAP19  TPM4  RBM10  PPIL3  TPR  RBM17  PPL  TPX2  RBMX  PPP1R13L  TSSC1  RCN1  PPP2R1A  TXNDC9  RFC2  PRCC  UBA6  RFC4  PRDX1  UBAP2  RIF1  PRKAR2A  UBAP2L  RING1  PRMT5  UBE2I  RNPC2  PRPF31  UBE2S  RSN  PSMA5  UBL4A  RTF1  PSMC6  UPF1  SCYE1  PSMD4  UPF3B  SEC13  PUF60  USF2  SEC16A  PUM1  UTP14A  SEC23A  QKI  VIM  SEC31A  RAB6IP2  WDR48  SEH1L  RACGAP1  WDR57  SEPTIN 9  RAD23B  WDR68  SF3B1  RANBP2  WDR77  SF3B3  RBM10  YLPM1  SFRS10  RBM12  YTHDF1  SFRS2IP  RBM17  YY1  SFRS7  RBM25  ZNF148  SH3GL1  RBM4  ZNF326  SH3GLB2  RBM9  ZNF330  SKIV2L2  RBMS2  ZNF830  SMARCA5  RCC2  SMARCC1  RCN1  SMARCC2  RCOR1  SMC1L1  RDBP  SMC2  RFC1  SMC4L1  RFC4  SMCHD1  RIF1  SND1  RING1  SNX12  RNASEH2A  SNX2  RNF219  SP1  RNPC2  SPAG5  RPAP3  SPG20  RPL10  SRFBP1  RPL13  SRP54  RPL23  SRP72  RPLP0  SRRM1  RPRC1  SRRM2  RPS27A  SSRP1  RSN  STAT5A  RTF1  STRAP  RUFY1  SULT1A1  S100A4  SUMO1  SAP30  SVIL  SART1  TANC1  SCYE1  TARDBP  SCYL2 c The Authors Journal compilation c 2009 Biochemical Society CNOT7 and CNOT8 form different human Ccr4-Not complexes CNOT2  CNOT3L  CNOT6  CNOT7  CNOT8  CNOT9  CNOT10  CNOT35   TBC1D15  SEC13  TBL1XR1  SEC16A  TCP1  SEC31A  TFG  SEH1L  TJP1  SERBP1  TJP2  SF3B2  TLE3  SFN  TLN1  SFRS2IP  TMPO  SH3GL1  TNNI2  SH3GLB2  TNPO1  SHC1  TNRC15  SKIV2L2  TNRC6B  SLU7  TOP2A  SMARCA5  TPR  SMARCC2  TPX2  SMC1L1  TRAFD1  SMU1  TRIP13  SNRP70  TSG101  SNRPD2  TSSC1  SNW1  TUBA4A  SNX12  U2AF2  SP1  UACA  SPG20  UBA1  SR140  UBA6  SRFBP1  UBAP2  SRRM1  UBAP2L  SRRM2  UBE2M  STAM2  UBR4  STMN2  UBXD7  STRAP  UFD1L  SUMO1  UPF1  SYNPO  UPF3B  TANC1  USP1  TARDBP  USP10  TBC1D15  USP19  TBL1XR1  VCL  TCEB1  VCPIP1  TCEB2  VDP  TCF3  VIM  TCP1  WDR48  TFDP1  WDR57  TFPT  WNK1  TIAL1  WRNIP1  TJP1  XPO1  TJP2  XPO2  TKT  YAF2  TLE3  YLPM1  TLN1  YTHDF1  TMPO  YWHAQ  TNNI2  ZAK  TNRC15  ZC3H11A  TNRC6B  ZC3HAV1  TOB1  ZC3HC1  TOB2  ZCCHC8  TPI1  ZNF185  TPR  ZNF326  ZNF598 Table S3 Overlap of substoichiometric Ccr4-Not interactors with yeast interologues from the HomoMINT database Unique peptide counts of the overlapping Ccr4-Not interactors (identified protein given as gene name) after MS analyses of purified Ccr4-Not complexes using the indicated tagged protein are shown.
Unique peptide Tagged protein   Identified protein  CNOT2  CNOT3L  CNOT6  CNOT7  CNOT8  CNOT9 
